Showing results (1-10 of 625) with videos related to
Sort By:
Pageof 63
Bulletin Du Cancer|April 22, 1999
[High-dose melphalan in patients with multiple myeloma]P Moreau, M Le Bonniec, J L HarousseauBone Marrow Transplantation|March 2, 2011
New developments in conditioning regimens before auto-SCT in multiple myelomaP Moreau, M Attal, J L HarousseauAnticancer Research|November 1, 1994
Pharmacokinetics of high-dose melphalan in adults: influence of renal functionM F Kergueris, N Milpied, P Moreau, et al.The Journal of Antimicrobial Chemotherapy|October 1, 1992
Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patientsP Moreau, N Milpied, N Fayette, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 6, 2002
[Autologous peripheral blood selected CD34+ cell transplantation in the treatment of multiple myeloma]X Tang, N Morineau, N Milpied, et al.La Revue De Medecine Interne|January 1, 1996
[Fusaria infection in patients with neutropenia: apropos of 3 cases]P Chevalet, M Tiab, M Miegeville, et al.British Journal of Haematology|July 11, 2000
A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myelomaP Moreau, J L Harousseau, J Wijdenes, et al.Bone Marrow Transplantation|September 5, 2002
Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patientsM Baudard, A Vincent, P Moreau, et al.Nouvelle Revue Francaise D'Hematologie|December 1, 1994
Administration of granulocyte colony-stimulating factor from day 7 after autologous bone marrow transplantation: effects on neutropenia and duration of hospitalizationP Moreau, S Le Tortorec, B Mahé, et al.Leukemia|September 27, 2003
t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myelomaR Garand, H Avet-Loiseau, F Accard, et al.Pageof 63